ImmunoPrecise Antibodies Ltd (IPA)
0.3425
-0.01
(-1.69%)
USD |
NASDAQ |
Nov 22, 13:09
ImmunoPrecise Antibodies Normalized PE Ratio
Normalized PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Normalized PE Ratio Data
| Date | Value |
|---|---|
| December 28, 2015 | -- |
| December 24, 2015 | -- |
| December 23, 2015 | -- |
| December 22, 2015 | -- |
| December 21, 2015 | -- |
| December 18, 2015 | -- |
| December 17, 2015 | -- |
| December 16, 2015 | -- |
| Date | Value |
|---|---|
| December 15, 2015 | -- |
| December 14, 2015 | -- |
| December 11, 2015 | -- |
| December 10, 2015 | -- |
| December 09, 2015 | -- |
| December 08, 2015 | -- |
| December 07, 2015 | -- |
| December 04, 2015 | -- |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
Normalized PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median